DE69732308D1 - Arzneistoffverabreichungssystem mit hyaluronsäure - Google Patents

Arzneistoffverabreichungssystem mit hyaluronsäure

Info

Publication number
DE69732308D1
DE69732308D1 DE69732308T DE69732308T DE69732308D1 DE 69732308 D1 DE69732308 D1 DE 69732308D1 DE 69732308 T DE69732308 T DE 69732308T DE 69732308 T DE69732308 T DE 69732308T DE 69732308 D1 DE69732308 D1 DE 69732308D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
disposal system
drug disposal
drug
hyaluronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732308T
Other languages
English (en)
Other versions
DE69732308T2 (de
Inventor
Christopher Marriott
Gary Peter Martin
Mark Barry Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of DE69732308D1 publication Critical patent/DE69732308D1/de
Application granted granted Critical
Publication of DE69732308T2 publication Critical patent/DE69732308T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69732308T 1996-09-27 1997-09-29 Arzneistoffverabreichungssystem mit hyaluronsäure Expired - Lifetime DE69732308T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72290996A 1996-09-27 1996-09-27
US722909 1996-09-27
PCT/GB1997/002665 WO1998013024A2 (en) 1996-09-27 1997-09-29 Hyaluronic drug delivery system

Publications (2)

Publication Number Publication Date
DE69732308D1 true DE69732308D1 (de) 2005-02-24
DE69732308T2 DE69732308T2 (de) 2005-06-02

Family

ID=24903936

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732308T Expired - Lifetime DE69732308T2 (de) 1996-09-27 1997-09-29 Arzneistoffverabreichungssystem mit hyaluronsäure

Country Status (6)

Country Link
US (1) US6890901B2 (de)
EP (1) EP0963196B1 (de)
AU (1) AU740111B2 (de)
CA (1) CA2266622C (de)
DE (1) DE69732308T2 (de)
WO (1) WO1998013024A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875753B1 (en) 1996-03-14 2005-04-05 The Governors Of The University Of Alberta Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
GB9818278D0 (en) * 1998-08-22 1998-10-14 Smith & Nephew Compositions
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
JP3802348B2 (ja) * 1999-01-18 2006-07-26 エルジー ライフ サイエンシズ エルティーディー． タンパク質薬物または抗原を含む、親油性微細粒子およびそれを含む剤形
US6593308B2 (en) * 1999-12-03 2003-07-15 The Regents Of The University Of California Targeted drug delivery with a hyaluronan ligand
EP1387676A2 (de) * 2001-05-01 2004-02-11 Angiotech Pharmaceuticals, Inc. Zusammensetzung enthaltend eine substanz mit anti-mikrotubulärer wirkung und ein polysaccharid oder polypeptid und ihre verwendung zur herstellung eines medikaments zur behandlung von entzündlichen erkrankungen
US20030157161A1 (en) * 2001-05-01 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
KR100426636B1 (ko) * 2001-05-18 2004-04-08 한국과학기술연구원 주사 가능한 젤 상의 조성물 및 그의 제조방법
ATE425178T1 (de) 2001-10-19 2009-03-15 Isotechnika Inc Synthese von cyclosporinanalogen
US7144870B2 (en) * 2002-02-15 2006-12-05 Research Development Foundation Hyaluronic acid mediated adenoviral transduction
DE10246340A1 (de) * 2002-10-04 2004-04-29 Wohlrab, David, Dr. Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
US9539202B2 (en) * 2006-04-28 2017-01-10 Universidad Complutense De Madrid Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
FR2921259B1 (fr) * 2007-09-26 2015-02-13 Lvmh Rech Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
ITMI20072348A1 (it) 2007-12-17 2009-06-18 Medichem Srl Metodo per la rigenerazione cellulare di acido ialuronico e relativa composizione cosmetica
CL2008002730A1 (es) * 2008-09-12 2008-10-24 Roberto Figueroa Liza Patricio Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil
WO2010077165A1 (en) * 2008-12-31 2010-07-08 Obschestvo S Ogranichennoi Otvetstvennostju Scientific Company Flamena Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US20120082717A1 (en) * 2009-06-05 2012-04-05 Snu R&Db Foundation Complex, multilayer using the same, and device coated with the multilayer
US20100331819A1 (en) * 2009-06-24 2010-12-30 Abbott Cardiovascular Systems Inc. Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy
WO2014039012A1 (en) * 2012-09-06 2014-03-13 Nanyang Technological University Hyaluronic acid-based drug delivery systems
US20160151283A1 (en) 2014-11-27 2016-06-02 Icnoderm S.R.L. Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process
KR101713118B1 (ko) * 2015-08-28 2017-03-10 서강대학교산학협력단 세포외기질 전달용 리포솜
KR101749425B1 (ko) 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
JP2554880B2 (ja) * 1987-05-07 1996-11-20 ポーラ化成工業株式会社 皮膚化粧料
FR2622104B1 (fr) * 1987-10-22 1990-03-30 Bioetica Sa Procede de stabilisation de phases lamellaires lipidiques hydratees, par ex. de liposomes, composition de phases lamellaires lipidiques hydratees, par ex. des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes et utilisation en pharmacie ou en cosmetologie
US5244672A (en) 1988-12-02 1993-09-14 Coletica Composition containing liposomes stabilized by a stabilizing support based on atelocollagen and glycosaminoglycans
FR2643909B1 (fr) 1989-03-03 1993-01-22 Bioetica Sa Composition de base pour la preparation d'une composition cosmetique formant composition capillaire et composition cosmetique formant composition capillaire ainsi preparee, contenant de l'heparine ou de l'heparane sulfate
CA1340994C (en) 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
JPH03143540A (ja) 1989-10-26 1991-06-19 Agency Of Ind Science & Technol 新規な乳化安定剤
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
KR910016921A (ko) 1990-03-14 1991-11-05 파디아 에스. 피. 에이 인간의 모양체 신경원영양 인자, 그를 코딩하는 dna 서열 및 재조합 기술에 의한 그의 제조방법
CA2061703C (en) 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
JPH05506251A (ja) 1991-02-14 1993-09-16 バクスター、インターナショナル、インコーポレイテッド リポソームへの成長ホルモン類の結合
DE69113036T2 (de) * 1991-02-14 1996-05-02 Baxter Int Verzögerte arzneistoffabgabe durch topische anwendung bioadhäsiver liposomen.
JP3407072B2 (ja) * 1991-02-14 2003-05-19 バクスター、インターナショナル、インコーポレイテッド リポソームへの認識物質の結合
EP0525154A1 (de) 1991-02-14 1993-02-03 Baxter International Inc. Wechselwirkung zwischen bioadhäsiven Liposomen und Zielstrukturen
US5344644A (en) 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
US5654000A (en) * 1992-07-28 1997-08-05 Poli Industria Chimica S.P.A. Pharmaceutical compositions for transmucosal delivery of peptides
US5437867A (en) 1993-03-19 1995-08-01 Collaborative Laboratories Solubilizing, thickening and emulsifying cosmetic composition and process for preparation of same
ES2147744T3 (es) 1993-03-24 2000-10-01 Collaborative Lab Inc Sistema de administracion cosmetico para acido salicilico y proceso para su preparacion.
CA2170142C (en) * 1993-08-27 2010-05-25 Jose M. Wade Composition and method for stimulation of reproductive performance
EP0697214A1 (de) * 1994-07-19 1996-02-21 Vestar, Inc. Pharmazeutische Formulierungen mit liposomalem Cyclosporin
CA2204493C (en) * 1994-11-04 2009-04-14 Hermann Katinger Application of superoxide dismutase in liposomes
JP2000507915A (ja) * 1995-10-23 2000-06-27 ハイアル・ファーマシューティカル・オーストラリア・リミテッド 遺伝子療法のためのｄｎａ担体としてのヒアルロン酸および異常な網膜血管新生を治療するためのｖｅｇｆアンチセンスｄｎａ
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith

Also Published As

Publication number Publication date
WO1998013024A2 (en) 1998-04-02
EP0963196B1 (de) 2005-01-19
US20010005501A1 (en) 2001-06-28
AU4468197A (en) 1998-04-17
CA2266622A1 (en) 1998-04-02
US6890901B2 (en) 2005-05-10
DE69732308T2 (de) 2005-06-02
AU740111B2 (en) 2001-11-01
EP0963196A2 (de) 1999-12-15
CA2266622C (en) 2006-08-15
WO1998013024A3 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
DE69732308D1 (de) Arzneistoffverabreichungssystem mit hyaluronsäure
ATE255438T1 (de) Einmalspritze
DK0963211T3 (da) Hypodermisk injektionssystem
DE59701787D1 (de) Medikamenten-dosiersystem
DE69630462D1 (de) Luer-Verbindungssystem
DE69730666D1 (de) Stentanbringungssystem
DE69731915D1 (de) Stentanbringungssystem
DE69510024T2 (de) Spritze
DE69605402D1 (de) Infusionssystem
DE19580298T1 (de) Apherese-System
DE59813222D1 (de) Kathetersystem
DE69432167D1 (de) System zur Kontrastmittelabgabe
DE69515391D1 (de) Narkosesystem
DE69531544D1 (de) Kathetersystem
DE69536007D1 (de) Kathetersystem
FI971279A (fi) Lääkkeitä
DE69825987D1 (de) Kathetersystem
DE69410880D1 (de) Medizinisches System
DE69634333D1 (de) Batterieladesystem
DE69520595D1 (de) Warenträgersystem
DE59707793D1 (de) Umrichtersystem
NO985571D0 (no) Legemiddel for autoimmunsykdommer
BR9503004A (pt) Conjunto de seringa
ATA37796A (de) Regalsystem
KR970053552U (ko) 동물용 연속주사기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition